Cypress Capital Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.98M | Sell |
47,312
-1,115
| -2% | -$147K | 0.56% | 43 |
|
|
2026
Q1 | $6.75M | Sell |
48,427
-159
| -0.3% | -$22.3K | 0.76% | 37 |
|
|
2025
Q4 | $5.96M | Sell |
48,586
-18
| -0% | -$2.19K | 0.67% | 40 |
|
|
2025
Q3 | $5.4M | Buy |
48,604
+71
| +0.1% | +$8.07K | 0.65% | 38 |
|
|
2025
Q2 | $5.38M | Buy |
48,533
+551
| +1% | +$58.6K | 0.67% | 40 |
|
|
2025
Q1 | $5.38M | Sell |
47,982
-1,129
| -2% | -$116K | 0.7% | 40 |
|
|
2024
Q4 | $4.54M | Sell |
49,111
-1,173
| -2% | -$106K | 0.56% | 47 |
|
|
2024
Q3 | $4.22M | Sell |
50,284
-635
| -1% | -$48.5K | 0.47% | 53 |
|
|
2024
Q2 | $3.49M | Sell |
50,919
-89
| -0.2% | -$5.94K | 0.42% | 58 |
|
|
2024
Q1 | $3.74M | Sell |
51,008
-399
| -0.8% | -$30.7K | 0.45% | 60 |
|
|
2023
Q4 | $4.16M | Sell |
51,407
-4,850
| -9% | -$377K | 0.54% | 51 |
|
|
2023
Q3 | $4.22M | Sell |
56,257
-1,802
| -3% | -$139K | 0.61% | 46 |
|
|
2023
Q2 | $4.47M | Sell |
58,059
-3,371
| -5% | -$269K | 0.65% | 44 |
|
|
2023
Q1 | $5.1M | Sell |
61,430
-12,256
| -17% | -$1.02M | 0.78% | 35 |
|
|
2022
Q4 | $6.33M | Sell |
73,686
-89
| -0.1% | -$7.05K | 0.95% | 29 |
|
|
2022
Q3 | $4.55M | Buy |
73,775
+982
| +1% | +$61.9K | 0.76% | 40 |
|
|
2022
Q2 | $4.5M | Buy |
72,793
+7,445
| +11% | +$461K | 0.69% | 41 |
|
|
2022
Q1 | $3.88M | Buy |
65,348
+12,484
| +24% | +$798K | 0.48% | 62 |
|
|
2021
Q4 | $3.84M | Buy |
52,864
+9,527
| +22% | +$656K | 0.48% | 60 |
|
|
2021
Q3 | $3.03M | Sell |
43,337
-964
| -2% | -$67.7K | 0.41% | 66 |
|
|
2021
Q2 | $3.05M | Sell |
44,301
-313
| -0.7% | -$20.9K | 0.41% | 69 |
|
|
2021
Q1 | $2.88M | Buy |
44,614
+951
| +2% | +$61.3K | 0.41% | 69 |
|
|
2020
Q4 | $2.54M | Sell |
43,663
-2,076
| -5% | -$125K | 0.38% | 68 |
|
|
2020
Q3 | $2.89M | Sell |
45,739
-9,603
| -17% | -$666K | 0.48% | 58 |
|
|
2020
Q2 | $4.26M | Buy |
55,342
+7,759
| +16% | +$595K | 0.78% | 37 |
|
|
2020
Q1 | $3.56M | Buy |
47,583
+3,738
| +9% | +$258K | 0.82% | 40 |
|
|
2019
Q4 | $2.85M | Sell |
43,845
-1,530
| -3% | -$99.6K | 0.51% | 63 |
|
|
2019
Q3 | $2.88M | Sell |
45,375
-928
| -2% | -$60.7K | 0.55% | 58 |
|
|
2019
Q2 | $3.13M | Buy |
46,303
+1,717
| +4% | +$113K | 0.62% | 53 |
|
|
2019
Q1 | $2.9M | Sell |
44,586
-3,365
| -7% | -$224K | 0.59% | 53 |
|
|
2018
Q4 | $3M | Sell |
47,951
-2,882
| -6% | -$201K | 0.69% | 47 |
|
|
2018
Q3 | $3.92M | Buy |
50,833
+10,014
| +25% | +$756K | 0.74% | 44 |
|
|
2018
Q2 | $2.89M | Sell |
40,819
-2,980
| -7% | -$210K | 0.6% | 56 |
|
|
2018
Q1 | $3.3M | Buy |
43,799
+2,621
| +6% | +$208K | 0.69% | 50 |
|
|
2017
Q4 | $2.95M | Sell |
41,178
-1,067
| -3% | -$81K | 0.61% | 56 |
|
|
2017
Q3 | $3.42M | Buy |
42,245
+500
| +1% | +$38.2K | 0.73% | 46 |
|
|
2017
Q2 | $2.96M | Buy |
41,745
+25
| +0.1% | +$1.66K | 0.65% | 55 |
|
|
2017
Q1 | $2.83M | Sell |
41,720
-725
| -2% | -$51K | 0.66% | 56 |
|
|
2016
Q4 | $3.04M | Buy |
42,445
+296
| +0.7% | +$22K | 0.72% | 49 |
|
|
2016
Q3 | $3.33M | Sell |
42,149
-5,716
| -12% | -$464K | 0.8% | 44 |
|
|
2016
Q2 | $3.99M | Sell |
47,865
-4,075
| -8% | -$362K | 0.93% | 38 |
|
|
2016
Q1 | $4.77M | Sell |
51,940
-3,069
| -6% | -$277K | 1.17% | 31 |
|
|
2015
Q4 | $5.57M | Sell |
55,009
-3,480
| -6% | -$362K | 1.34% | 27 |
|
|
2015
Q3 | $5.74M | Buy |
58,489
+1,945
| +3% | +$216K | 1.42% | 23 |
|
|
2015
Q2 | $6.62M | Sell |
56,544
-675
| -1% | -$73.8K | 1.52% | 20 |
|
|
2015
Q1 | $5.62M | Buy |
57,219
+7,037
| +14% | +$715K | 1.28% | 27 |
|
|
2014
Q4 | $4.73M | Sell |
50,182
-4,943
| -9% | -$511K | 1.1% | 31 |
|
|
2014
Q3 | $5.87M | Sell |
55,125
-530
| -1% | -$51.9K | 1.39% | 21 |
|
|
2014
Q2 | $4.62M | Buy |
55,655
+2,295
| +4% | +$179K | 1.08% | 29 |
|
|
2014
Q1 | $3.78M | Buy |
53,360
+4,150
| +8% | +$325K | 0.93% | 36 |
|
|
2013
Q4 | $3.7M | Sell |
49,210
-3,200
| -6% | -$223K | 0.91% | 39 |
|
|
2013
Q3 | $3.29M | Sell |
52,410
-400
| -0.8% | -$23.9K | 0.81% | 44 |
|
|
2013
Q2 | $2.71M | Buy |
+52,810
| New | +$2.75M | 0.57% | 64 |
|
Other funds holding GILD
N
Cypress Capital Group's GILD Position: Q2 2026 in Review
Cypress Capital Group reduced its Gilead Sciences (GILD) stake by 2.3% in Q2 2026, selling an estimated $147K and leaving 47,312 shares worth $5.98M. The position accounts for 0.56% of the portfolio, ranked #43.
Cypress Capital Group first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.75M in Q1 2026. 1,755 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Cypress Capital Group held 47,312 shares of Gilead Sciences worth $5.98M as of Q2 2026.
- Cypress Capital Group sold 1,115 Gilead Sciences shares in Q2 2026, an estimated $147K.
- Gilead Sciences made up 0.56% of Cypress Capital Group's portfolio in Q2 2026, its #43 holding.
- Cypress Capital Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
- Cypress Capital Group's Gilead Sciences position peaked at $6.75M in Q1 2026.
- 1,755 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Cypress Capital Group's 13F filing for Q2 2026, filed 5 Aug 2026.